TCL Archive Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs. April 14, 2006
TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive DCCP Board Gives Concept Approval To RFA For Biochemical Epidemiolgy, New And Recompeting Contract Program September 23, 1983
TCL Archive In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested August 31, 1979
